retatrutide resting heart rate side effects: what the trials show and how to manage them Retatrutide and Heart Issues: Cardiovascular

Gallbladder disease risk may be increased with GLP-1 receptor agonists, particularly with substantial weight loss

Proc Natl Acad Sci USA 104:1506915074 [DOI] [PMC free article] [PubMed] [Google Scholar] Shin YK, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang HJ, Mattson MP, Drucker DJ, Egan JM, Munger SD 2008 Modulation of taste sensitivity by GLP-1 signaling

Glucagon-like peptide-1 (GLP-1) receptor agonists make up a class of medications used for the treatment of type 2 diabetes and obesity

Liver damage or hepatitis

However, modern evidence reveals that the gustatory system is a dynamic neuroendocrine system, crucial for nutritional sensing, metabolic regulation, and behavioral adaptation ( Built on this paradigm, a growing body of evidence indicates that GLP-1 acts beyond its classical endocrine role, directly influencing the gustatory system

This is particularly significant as diabetes increases the risk of cardiovascular complications